Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000315066-26-002833·Silence Therapeutics plc
Schedule 13G ownership disclosure
Silence Therapeutics plc
COMMON STOCK · CUSIP: G8128Y157
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 13,180,206.00 · Class: 7.1%
- Abigail P. Johnson
Shares: 13,180,206.00 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-002833
- Form type
- SCHEDULE 13G
- Filer
- Silence Therapeutics plc
- CIK
- CIK 1479615
- Filed
- Nov 05, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership